Jiuhe Kit develops and supplies IVD products for international healthcare markets, combining manufacturing resources, R&D capabilities, and professional trading experience. Its diagnostic portfolio covers rapid tests, immunoassay products, analyzers, and other laboratory solutions for different clinical and screening environments. A Rapid Antigen Covid Test can be positioned within this portfolio as a practical option for preliminary respiratory screening where rapid turnaround is required. Product selection should consider specimen type, intended users, testing environment, regulatory status, and local market requirements. Jiuhe Kit states that its quality system is aligned with ISO13485 requirements and supports international product development. For distributors, the advantage is a broader sourcing platform rather than a single diagnostic category. Rapid Antigen Covid Test products can therefore be combined with complementary IVD products to build customized portfolios for clinics, occupational health providers, pharmacies, and regional healthcare programs.